Cerenome, Inc. announced it will present interim data from its ongoing ReSPECT-LMM multidose study of REYOBIQ, an investigational radiotherapeutic for leptomeningeal metastases, at the 2026 Society for Neuro-Oncology Annual Meeting. The study evaluates repeated doses of REYOBIQ in patients with this fatal condition, aiming to advance to a Phase 2 dose randomization study in 2027. The company will also host a symposium discussing diagnosis, treatment, and research advances for leptomeningeal metastases. This data is preliminary but important for developing new therapies in a disease with no approved treatments.
Cerenome's interim clinical update on the ReSPECT-LM trial provides context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Oct 27, 2026 17:43 WIB: out of 150 priced US health-sector stocks, 69 rose and 68 fell. Notable movers include INO (Inovio Pharmaceuticals Inc) at USD 0.90 with a 3.78% gain and 87% buy order activity, BNGO (BioNano Genomics Inc) at USD 1.12 down 3.45% with 100% sell orders, and CRON (Cronos Group Inc) at USD 3.41 up 3.02% with a typical hold time of 23 days.
Black Ore introduced Black Ore for Small Firms, an AI-powered tax automation platform designed for small to mid-sized accounting practices. It integrates with Intuit tax software, enabling firms to handle more clients without increasing staff by auto...
Alm. Brand A/S executed a share buy-back program from October 20 to 26, 2026, purchasing 1.81 million shares at an average price of DKK 17.41 each. This brings the total shares bought under the program to nearly 19.58 million, costing about DKK 324 m...
Hyphenate, an autonomous finance platform, secured $45 million in Series A funding following an 86-fold revenue increase and an 11-fold growth in customers over 12 months. Its AI-driven agents now handle 90% of routine finance work, such as invoicing...
CareCloud has named Mitchell Brie as Chief Compliance Officer to lead its growing healthcare compliance business. Brie, founder of Empower Healthcare & Compliance Partners (acquired by CareCloud), will oversee corporate compliance and continue as Pre...
Man Group PLC has publicly disclosed holding a 5.64% interest in Vesuvius plc, including direct shares and cash-settled derivatives. This disclosure is related to an ongoing offer involving RHI Magnestia N.V., which is also named in the filing. The d...
